» Articles » PMID: 38342617

Self-Reinforced Bimetallic Mito-Jammer for Ca Overload-Mediated Cascade Mitochondrial Damage for Cancer Cuproptosis Sensitization

Abstract

Overproduction of reactive oxygen species (ROS), metal ion accumulation, and tricarboxylic acid cycle collapse are crucial factors in mitochondria-mediated cell death. However, the highly adaptive nature and damage-repair capabilities of malignant tumors strongly limit the efficacy of treatments based on a single treatment mode. To address this challenge, a self-reinforced bimetallic Mito-Jammer is developed by incorporating doxorubicin (DOX) and calcium peroxide (CaO) into hyaluronic acid (HA) -modified metal-organic frameworks (MOF). After cellular, Mito-Jammer dissociates into CaO and Cu in the tumor microenvironment. The exposed CaO further yields hydrogen peroxide (HO) and Ca in a weakly acidic environment to strengthen the Cu-based Fenton-like reaction. Furthermore, the combination of chemodynamic therapy and Ca overload exacerbates ROS storms and mitochondrial damage, resulting in the downregulation of intracellular adenosine triphosphate (ATP) levels and blocking of Cu-ATPase to sensitize cuproptosis. This multilevel interaction strategy also activates robust immunogenic cell death and suppresses tumor metastasis simultaneously. This study presents a multivariate model for revolutionizing mitochondria damage, relying on the continuous retention of bimetallic ions to boost cuproptosis/immunotherapy in cancer.

Citing Articles

Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application.

Imam M, Ji J, Zhang Z, Yan S Front Pharmacol. 2025; 15:1493188.

PMID: 39867656 PMC: 11757020. DOI: 10.3389/fphar.2024.1493188.


The Impact of Calcium Overload on Cellular Processes: Exploring Calcicoptosis and Its Therapeutic Potential in Cancer.

Gielecinska A, Kciuk M, Kontek R Int J Mol Sci. 2025; 25(24.

PMID: 39769488 PMC: 11679949. DOI: 10.3390/ijms252413727.


Graphene Quantum Dot Sensitized Heterojunctions Induce Tumor-Specific Cuproptosis to Boost Sonodynamic and Chemodynamic Enhanced Cancer Immunotherapy.

Yan L, Chang L, Tian Y, Hu J, Cao Z, Guo X Adv Sci (Weinh). 2024; 12(7):e2410606.

PMID: 39716968 PMC: 11831527. DOI: 10.1002/advs.202410606.


A Novel "Three-in-One" Copper-Based Metal-Organic Framework Nanozyme Eradicates Colorectal Cancer and Overcomes Chemoresistance for Tumor Therapy.

Dong S, Cao H, Yuan Y, Liang S, Fu Z, Shi W Adv Sci (Weinh). 2024; 12(6):e2413422.

PMID: 39629925 PMC: 11809406. DOI: 10.1002/advs.202413422.


Synthesis of Closely-Contacted CuO-CoWO Nanosheet Composites for Cuproptosis Therapy to Tumors With Sonodynamic and Photothermal Assistance.

Yang Z, Li Z, Yang C, Meng L, Guo W, Jing L Adv Sci (Weinh). 2024; 12(2):e2410621.

PMID: 39573907 PMC: 11727377. DOI: 10.1002/advs.202410621.


References
1.
Wang Y, Wang J, Gou K, Kang W, Guo X, Zhu K . pH/HO Dual-Responsive Chiral Mesoporous Silica Nanorods Coated with a Biocompatible Active Targeting Ligand for Cancer Therapy. ACS Appl Mater Interfaces. 2021; 13(30):35397-35409. DOI: 10.1021/acsami.1c08532. View

2.
Jia C, Guo Y, Wu F . Chemodynamic Therapy via Fenton and Fenton-Like Nanomaterials: Strategies and Recent Advances. Small. 2021; 18(6):e2103868. DOI: 10.1002/smll.202103868. View

3.
Wu H, Chen F, You C, Zhang Y, Sun B, Zhu Q . Smart Porous Core-Shell Cuprous Oxide Nanocatalyst with High Biocompatibility for Acid-Triggered Chemo/Chemodynamic Synergistic Therapy. Small. 2020; 16(45):e2001805. DOI: 10.1002/smll.202001805. View

4.
Guo X, Yang N, Ji W, Zhang H, Dong X, Zhou Z . Mito-Bomb: Targeting Mitochondria for Cancer Therapy. Adv Mater. 2021; 33(43):e2007778. DOI: 10.1002/adma.202007778. View

5.
Yang Y, Li S, Wang Y, Zhao Y, Li Q . Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective. Signal Transduct Target Ther. 2022; 7(1):329. PMC: 9482625. DOI: 10.1038/s41392-022-01168-8. View